Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Conference, Product/Service, Trade Show, Award

Credence MedSystems Receives Award for Best Innovation in Drug Delivery Devices


Credence MedSystems, an innovator in injectable drug delivery technology for the biopharmaceutical industry, has received the Pharmapack Award for its Connecttm Auto-Sensing Injection System. The Connecttm was voted by a panel of pharmaceutical industry executives to be the Best Innovation in Drug Delivery Devices at the Pharmapack conference February 5 and 6 in Paris.

The Credence Connecttm brings digital connectivity to any pre-filled syringe for the delivery of injectable medications. It incorporates automatic real-time monitoring and transmission of critical injection data into a reusable ergonomic finger grip. The Connecttm enables healthcare providers and self-injecting patients to automatically collect data and receive feedback on the success of the injection, while improving usability of the syringe. "The Connecttm can deliver value for clinical studies and commercial applications," states John A. Merhige, Credence's Chief Commercial Officer. "It can promote proper use and drive compliance, characterize patient use patterns, and facilitate important communication and other novel business opportunities in the healthcare ecosystem."

"This is another great honor for Credence," added Chief Operating Officer Jeff Tillack. "We thank Pharmapack for promoting and rewarding innovation. Credence is proud to have won this award again." Credence received the same honor at the 2015 Pharmapack conference for its Companion® Safety Syringe System. Credence is currently working with several pharmaceutical manufacturers towards implementation of the Companion® system for delivery of their innovative drug products.

Merhige continued, "Probably the fastest impact we can have is on improving the integrity of clinical trial data. By providing Pharma with actual use data, obtained via remote monitoring, the Connecttm supports informed arguments on data inclusion when determining safety and efficacy of new drugs. And it improves the economics of managing the studies." The Connecttm was first introduced at Pharmapack. "We look forward to discussing with our Pharma partners the most impactful implementation of this new technology."

About Credence MedSystems, Inc.

Credence MedSystems is an innovator of drug delivery devices that solve unmet market needs. Credence's philosophy of Innovation Without Change allows our customers to impress and protect their end users while preserving their existing processes, sourcing strategies and preferred primary package components. The Companion® family of syringe systems includes proprietary needle retraction technology, syringe reuse prevention and other critical safety and usability features. The Dual Chamber Reconstitution platform offers single-step mixing and injection for drugs that require reconstitution at the time of delivery. Metered dose systems and other novel devices address the needs of specific therapeutic markets such as ocular therapies and cosmetic applications.

www.CredenceMed.com

+1-844-263-3797 (844-CMEDSYS)


These press releases may also interest you

at 09:05
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for...

at 09:05
Octapharma USA and BioMatrix Specialty Pharmacy are supporting a new investigator-initiated research study led by Kelly McCants, M.D., Medical Director of the Norton Heart & Vascular Institute in Louisville, Ky., focused on treating patients with the...

at 09:04
New brand CarryOntm has launched sparkling CBD waters as well as a brand mission to normalize the pursuit of mental wellbeing.  With over 56% of Americans reporting negative effects on their mental wellbeing, CarryOntm believes that the pursuit of...

at 09:00
InspectIR Systems, LLC, a purpose-driven company with proprietary measurement methods, devices and tools, has begun clinical trials aimed at detecting the novel coronavirus (COVID-19). InspectIR partnered with University of North Texas Associate...

at 09:00
CAN Community Health announced that Tampa Family Pharmacy founders Haley Miller and Crystal Campbell have resigned effective immediately and sold their remaining interest to CAN Community Health to spend more time with their respective families....

at 09:00
PTC Therapeutics, Inc. today announced that it will hold a series of virtual deep dive webinars discussing its therapeutic platforms and programs. The first webinar in the series will discuss its Bio-e platform on Friday, June 5 at 10:00 a.m. ET....



News published on 13 february 2020 at 01:05 and distributed by: